rs2304859
Positions:
Variant summary
Our verdict is Benign. Variant got -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1
The NM_015295.3(SMCHD1):āc.4137A>Gā(p.Ala1379Ala) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.306 in 1,603,420 control chromosomes in the GnomAD database, including 78,200 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (ā ā ).
Frequency
Genomes: š 0.30 ( 6924 hom., cov: 31)
Exomes š: 0.31 ( 71276 hom. )
Consequence
SMCHD1
NM_015295.3 synonymous
NM_015295.3 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: 0.324
Genes affected
SMCHD1 (HGNC:29090): (structural maintenance of chromosomes flexible hinge domain containing 1) This gene encodes a protein which contains a hinge region domain found in members of the SMC (structural maintenance of chromosomes) protein family. [provided by RefSeq, Dec 2011]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -21 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.6).
BP6
Variant 18-2750479-A-G is Benign according to our data. Variant chr18-2750479-A-G is described in ClinVar as [Benign]. Clinvar id is 260648.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr18-2750479-A-G is described in Lovd as [Benign].
BP7
Synonymous conserved (PhyloP=0.324 with no splicing effect.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.482 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SMCHD1 | NM_015295.3 | c.4137A>G | p.Ala1379Ala | synonymous_variant | 32/48 | ENST00000320876.11 | NP_056110.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SMCHD1 | ENST00000320876.11 | c.4137A>G | p.Ala1379Ala | synonymous_variant | 32/48 | 5 | NM_015295.3 | ENSP00000326603.7 |
Frequencies
GnomAD3 genomes AF: 0.297 AC: 45156AN: 151810Hom.: 6908 Cov.: 31
GnomAD3 genomes
AF:
AC:
45156
AN:
151810
Hom.:
Cov.:
31
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.345 AC: 82065AN: 237782Hom.: 15227 AF XY: 0.343 AC XY: 44174AN XY: 128892
GnomAD3 exomes
AF:
AC:
82065
AN:
237782
Hom.:
AF XY:
AC XY:
44174
AN XY:
128892
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.306 AC: 444643AN: 1451492Hom.: 71276 Cov.: 33 AF XY: 0.309 AC XY: 223004AN XY: 721618
GnomAD4 exome
AF:
AC:
444643
AN:
1451492
Hom.:
Cov.:
33
AF XY:
AC XY:
223004
AN XY:
721618
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.298 AC: 45204AN: 151928Hom.: 6924 Cov.: 31 AF XY: 0.300 AC XY: 22262AN XY: 74258
GnomAD4 genome
AF:
AC:
45204
AN:
151928
Hom.:
Cov.:
31
AF XY:
AC XY:
22262
AN XY:
74258
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
1709
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:6
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:3
Benign, criteria provided, single submitter | clinical testing | GeneDx | Mar 24, 2021 | - - |
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Benign, criteria provided, single submitter | clinical testing | Athena Diagnostics | Nov 02, 2018 | - - |
not specified Benign:1
Benign, criteria provided, single submitter | clinical testing | PreventionGenetics, part of Exact Sciences | - | - - |
Facioscapulohumeral muscular dystrophy 2 Benign:1
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Feb 01, 2024 | - - |
Arrhinia with choanal atresia and microphthalmia syndrome Benign:1
Benign, criteria provided, single submitter | clinical testing | Genome-Nilou Lab | Jul 15, 2021 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
RBP_binding_hub_radar
RBP_regulation_power_radar
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at